A research from Children’s Hospital of Philadelphia (CHOP) and Stanford University has unveiled the molecular structure of TRACeR-I, a protein platform designed to reprogram immune responses. Gaining deeper understanding of its intricate structure, researchers can enhance the design of this platform. TRACeR-I holds the potential to either directly modify immune cells or generate proteins that enable these cells to specifically target and eliminate cancer cells, offering new hope in the fight against cancer.
Researchers reveal and refine new immunotherapy platform
With increased potential to target cancer cells.
- Advertisement -
Explore more ..
High-fat diets and memory loss- A reversible story
Machine learning identifies early depression signals in facial patterns.
Why alcohol halts liver regeneration, even after quitting
New research links inflammation to faulty RNA processing
Breakthrough stool test could replace invasive colonoscopies
An artificial intelligence-based approach to diagnose colorectal cancer from the gut microbiota.
TRENDING
- Advertisement -